Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax UK Ltd) |
| BNF code | 1404000ATBEABBP |
| Virtual Medicinal Product | Generic Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials |
| Name | Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials |
| Abbreviated name | Nuvaxovid XBB.1.5 COVID-19 Vaccine 0.5ml inj multidose vials |
| Supplier | Novavax UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax UK Ltd) 10 dose 2 x 5 dose vials | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.